I've been in ZEN for over 8 years as well. Accumulated a lot of shares. I can be constructive. I think ZEN made a timing mistake with their news releases. I do not believe they knew Trebor RX did not have a mask approved by Health Canada, therefor they went ahead and claimed they thought it would be about 40 days. It wasn't until January that we became aware Trebor did not have an HC approved mask so back to square one it was.

The current share price is built on NR's and as time goes by without masks to market the share price will slowly devalues.

It was stated in late January we'd have news of the cytotoxicity testing, today is January 30 and no updates. Expect the share price to drop on Monday. The market is very aware of dates set by companies and it looks like ZEN is going to miss their second date in a row.

Don't get me wrong, I still see great value based on the speculation but keep in mind it is all speculation until masks are to market and cytotoxicity moves to the next stage.

GLTA